PeptideDB

PARP7-IN-16 free base 2136325-05-6

PARP7-IN-16 free base 2136325-05-6

CAS No.: 2136325-05-6

PARP7-IN-16 free base is the free form of PARP7-IN-16. PARP7-IN-16 free base is a selective and orally active PARP-1/2/7
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

PARP7-IN-16 free base is the free form of PARP7-IN-16. PARP7-IN-16 free base is a selective and orally active PARP-1/2/7 inhibitor with IC50 values of 0.94, 0.87 and 0.21 nM, respectively. PARP7-IN-16 can be used in the study of breast cancer and prostate cancer.

Physicochemical Properties


Molecular Formula C25H27FN4O4
Molecular Weight 466.50
CAS # 2136325-05-6
Appearance White to off-white solid powder
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


Targets PARP7 0.21 nM (IC50) PARP2 0.87 nM (IC50) PARP1 0.94 nM (IC50)
References

[1]. Discovery of Quinazoline-2,4(1 H,3 H)-dione Derivatives Containing a Piperizinone Moiety as Potent PARP-1/2 Inhibitors─Design, Synthesis, In Vivo Antitumor Activity, and X-ray Crystal Structure Analysis. J Med Chem. 2023 Oct 26;66(20):14095-14115.


Solubility Data


Solubility (In Vitro) DMSO : ~33.33 mg/mL (~71.45 mM; with ultrasonication (<60°C))
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.5 mg/mL (5.36 mM) (saturation unknown) in 10% DMSO +40% PEG300 +5% Tween-80 +45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution。
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.5 mg/mL (5.36 mM) (saturation unknown) in 10% DMSO +90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution。
For example, if 1 mL of working solution is to be prepared, You can add 100 μL of the 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD in saline and mix well.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

Solubility in Formulation 3: ≥ 2.5 mg/mL (5.36 mM) (saturation unknown) in 10% DMSO +90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution。
For example, if 1 mL of working solution is to be prepared, You can add 100 μL of the 25.0 mg/mL clear DMSO stock solution to 900 μL corn oil and mix well.

" (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.1436 mL 10.7181 mL 21.4362 mL
5 mM 0.4287 mL 2.1436 mL 4.2872 mL
10 mM 0.2144 mL 1.0718 mL 2.1436 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.